BioAdvance News

Niiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO

By WebmasterMay 24, 2012November 1st, 2024No Comments

Niiki Pharma to Present Final Phase I Clinical Data on Anti-Cancer Agent at ASCO
Read more here

Previous PostCeptaris Secures $10 Million in Series D-1 Financing
Next PostGalleon Pharmaceuticals Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression